Congratulations to AiM Medical Robotics for their successful $8.1 million Series A financing round. This major achievement, led by IQ Capital and 1540 Ventures, marks an exciting step forward for their groundbreaking MRI-compatible robotic platform. By combining deep clinical expertise and advanced engineering, AiM’s MRI-compatible robotic platform enables real-time, image-guided precision for surgeries treating conditions like Parkinson’s disease, epilepsy, and cancer. With this innovative technology, AiM is helping usher in a new era of safer procedures, improved patient outcomes, and tangible workflow efficiency benefits for hospitals and surgical teams worldwide.
Kudos to the entire AiM team and their world-class investors for driving technological progress in neurosurgical robotics and setting new standards for patient care and minimally invasive medicine.
